Frank W. Marcoux
Amministratore Delegato presso Portage Glasgow Ltd.
Profilo
Frank W.
Marcoux is currently the Chief Executive Officer at Portage Pharmaceutical Ltd., the Chief Executive Officer & Director at Portage Glasgow Ltd., and a Director at Opsidio LLC.
He was previously the Chief Scientific Officer at Portage Pharma Ltd.
and the Chief Scientific Officer at Portage Biotech, Inc.
Posizioni attive di Frank W. Marcoux
| Società | Posizione | Inizio |
|---|---|---|
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Direttore Tecnico/Scientifico/R&S | 04/06/2013 |
Opsidio LLC
 Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Direttore/Membro del Consiglio | - |
Portage Glasgow Ltd.
 Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Amministratore Delegato | - |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Amministratore Delegato | - |
Precedenti posizioni note di Frank W. Marcoux
| Società | Posizione | Fine |
|---|---|---|
| PORTAGE BIOTECH INC. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PORTAGE BIOTECH INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Portage Pharma Ltd.
Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Health Technology |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
Opsidio LLC
Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Health Technology |
Portage Glasgow Ltd.
Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Health Technology |
- Borsa valori
- Insiders
- Frank W. Marcoux
